Clinical Trial Update: A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer [Phase 3]

View source ↗

Summary

A Phase 3 trial of Esomeplazole (D961H) in Japanese pediatric patients with reflux esophagitis, gastric ulcer, or duodenal ulcer has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer
• Reflux Esophagitis

Drugs mentioned

• Esomeplazole (D961H) (Esomeplazole)

Snippet

Sponsor: AstraZeneca | Conditions: Reflux Esophagitis, Gastric Ulcer | Phase 3 | Status: COMPLETED | Results posted: 2026-03-04